News Daily News Shock’s Added Risk in Acute MI Restricted to the First Few Months After Discharge Caitlin E. Cox February 16, 2016
News Conference News ISET 2016 ‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study Michael O'Riordan February 08, 2016
News Daily News Leaving Significant Stenoses Untreated After PCI May Worsen 1-Year Outcomes: SCAAR Data Todd Neale February 01, 2016
News Daily News Complicaciones en el Laboratorio de Cateterización: Un Nuevo Análisis Define el Índice y Riesgos de los Episodios Trombóticos Intraoperatorios en el Manejo del SCA Shelley Wood January 21, 2016
News Daily News Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS Shelley Wood January 21, 2016
News Daily News High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients Michael O'Riordan January 12, 2016
News Daily News BP Lowering Reduces Vascular Risk Regardless of Baseline BP and Disease History Michael O'Riordan December 27, 2015
News Daily News CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI Caitlin E. Cox December 15, 2015
News Daily News AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients L.A. McKeown December 09, 2015
News Conference News AHA 2015 Varenicline Helps ACS Patients Quit Smoking, But Effect Wanes Todd Neale November 12, 2015
News Industry News One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015 October 20, 2015
News Daily News Test de troponina I de alta sensibilidad podría eliminar el IM en gran número de pacientes Todd Neale October 13, 2015
News Daily News High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients Todd Neale October 13, 2015
News Industry News Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA September 29, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Conference News ESC 2015 Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients L.A. McKeown August 31, 2015
News Industry News New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology August 20, 2015